Literature DB >> 23104325

Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality.

Vikrant V Sahasrabuddhe, Mark E Sherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23104325      PMCID： PMC3529599          DOI： 10.1093/jnci/djs453

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Authors:  Matti Lehtinen; Jorma Paavonen; Cosette M Wheeler; Unnop Jaisamrarn; Suzanne M Garland; Xavier Castellsagué; S Rachel Skinner; Dan Apter; Paulo Naud; Jorge Salmerón; Song-Nan Chow; Henry Kitchener; Júlio C Teixeira; James Hedrick; Genara Limson; Anne Szarewski; Barbara Romanowski; Fred Y Aoki; Tino F Schwarz; Willy A J Poppe; Newton S De Carvalho; Maria Julieta V Germar; Klaus Peters; Adrian Mindel; Philippe De Sutter; F Xavier Bosch; Marie-Pierre David; Dominique Descamps; Frank Struyf; Gary Dubin
Journal:  Lancet Oncol       Date:  2011-11-08       Impact factor: 41.316

Review 2.  Visual inspection methods for cervical cancer prevention.

Authors:  Rengaswamy Sankaranarayanan; Ashrafun Nessa; Pulikattil Okkuru Esmy; Jean-Marie Dangou
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-11-09       Impact factor: 5.237

3.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Authors:  You-Lin Qiao; John W Sellors; Paul S Eder; Yan-Ping Bao; Jeanette M Lim; Fang-Hui Zhao; Bernhard Weigl; Wen-Hua Zhang; Roger B Peck; Ling Li; Feng Chen; Qing-Jing Pan; Attila T Lorincz
Journal:  Lancet Oncol       Date:  2008-09-19       Impact factor: 41.316

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 5.  Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential.

Authors:  Vikrant V Sahasrabuddhe; Groesbeck P Parham; Mulindi H Mwanahamuntu; Sten H Vermund
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-12

6.  Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Authors:  Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt
Journal:  J Natl Cancer Inst       Date:  2010-02-05       Impact factor: 13.506

7.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

Authors:  Mei-Hwei Chang; San-Lin You; Chien-Jen Chen; Chun-Jen Liu; Chuan-Mo Lee; Shi-Ming Lin; Heng-Cheng Chu; Tzee-Chung Wu; Sheng-Shun Yang; Hsu-Sung Kuo; Ding-Shinn Chen
Journal:  J Natl Cancer Inst       Date:  2009-09-16       Impact factor: 13.506

8.  Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.

Authors:  Nicolas Van de Velde; Marie-Claude Boily; Mélanie Drolet; Eduardo L Franco; Marie-Hélène Mayrand; Erich V Kliewer; François Coutlée; Jean-François Laprise; Talía Malagón; Marc Brisson
Journal:  J Natl Cancer Inst       Date:  2012-10-27       Impact factor: 13.506

9.  Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia.

Authors:  Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Sharon Kapambwe; Krista S Pfaendler; Carla Chibwesha; Gracilia Mkumba; Victor Mudenda; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham
Journal:  PLoS Med       Date:  2011-05-17       Impact factor: 11.069

10.  Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.

Authors:  Aimée R Kreimer; Ana Cecilia Rodriguez; Allan Hildesheim; Rolando Herrero; Carolina Porras; Mark Schiffman; Paula González; Diane Solomon; Silvia Jiménez; John T Schiller; Douglas R Lowy; Wim Quint; Mark E Sherman; John Schussler; Sholom Wacholder
Journal:  J Natl Cancer Inst       Date:  2011-09-09       Impact factor: 13.506
View more
  1 in total

1.  Human papillomavirus vaccination: current indications and future directions.

Authors:  Leda Gattoc; Navya Nair; Kevin Ault
Journal:  Obstet Gynecol Clin North Am       Date:  2013-05-10       Impact factor: 2.844
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.